Suppr超能文献

p97 和组蛋白去乙酰化酶 6 在介导套细胞淋巴瘤细胞 DNA 修复中的功能协同作用。

Functional cooperativity of p97 and histone deacetylase 6 in mediating DNA repair in mantle cell lymphoma cells.

机构信息

Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Kanas City, KS, USA.

Department of Cancer Biology, The University of Kansas Cancer Center, Kanas City, KS, USA.

出版信息

Leukemia. 2019 Jul;33(7):1675-1686. doi: 10.1038/s41375-018-0355-y. Epub 2019 Jan 21.

Abstract

p97 is an ATPase that works in concert with histone deacetylase 6 (HDAC6), to facilitate the degradation of misfolded proteins by autophagosomes. p97 has also been implicated in DNA repair and maintaining genomic stability. In this study, we determined the effect of combined inhibition of p97 and HDAC6 activities in mantle cell lymphoma (MCL) cells. We report that treatment with p97 inhibitors induces dose-dependent apoptosis in MCL cells. The p97 inhibitor CB-5083 induces ER stress markers GRP78 and CHOP and results in the accumulation of polyubiquitylated proteins. Co-treatment with CB-5083 and the HDAC6 inhibitor ACY-1215 result in marked downregulation of CDK4, Cyclin D1, and BRCA1 levels without inhibiting autophagic flux. Consequently, treatment with CB-5083 accentuates DNA damage in response to treatment with ACY-1215 resulting in enhanced accumulation of H2AX-γ and synergistic apoptosis. Furthermore, ATM loss severely impairs phosphorylation of 53BP1 following co-treatment with CB-5083 and ACY-1215 in response to gamma irradiation. Finally, co-treatment CB-5083 and ACY-1215 results in reduced tumor volumes and improves survival in Z138C and Jeko-1 xenografts in NSG mice. These observations suggest that combined inhibition of p97 and HDAC6 abrogates resolution of proteotoxic stress and impairs DNA repair mechanisms in MCL cells.

摘要

p97 是一种 ATP 酶,与组蛋白去乙酰化酶 6(HDAC6)协同作用,促进自噬体对错误折叠蛋白质的降解。p97 还与 DNA 修复和维持基因组稳定性有关。在这项研究中,我们确定了联合抑制 p97 和 HDAC6 活性对套细胞淋巴瘤(MCL)细胞的影响。我们报告说,p97 抑制剂的治疗在 MCL 细胞中诱导剂量依赖性凋亡。p97 抑制剂 CB-5083 诱导内质网应激标志物 GRP78 和 CHOP,并导致多泛素化蛋白的积累。与 CB-5083 和 HDAC6 抑制剂 ACY-1215 共同治疗导致 CDK4、Cyclin D1 和 BRCA1 水平明显下调,而不抑制自噬通量。因此,CB-5083 的治疗加重了对 ACY-1215 治疗的 DNA 损伤,导致 H2AX-γ 的积累增加和协同凋亡。此外,ATM 缺失严重损害了 CB-5083 和 ACY-1215 共同处理后对 γ 辐射的反应中 53BP1 的磷酸化。最后,CB-5083 和 ACY-1215 的联合治疗导致 Z138C 和 Jeko-1 异种移植瘤在 NSG 小鼠中的肿瘤体积减少和存活率提高。这些观察结果表明,联合抑制 p97 和 HDAC6 可消除蛋白毒性应激的解决,并损害 MCL 细胞中的 DNA 修复机制。

相似文献

引用本文的文献

本文引用的文献

5
Proteasome inhibitors in cancer therapy.蛋白酶体抑制剂在癌症治疗中的应用。
Nat Rev Clin Oncol. 2017 Jul;14(7):417-433. doi: 10.1038/nrclinonc.2016.206. Epub 2017 Jan 24.
6
The molecular pathogenesis of mantle cell lymphoma.套细胞淋巴瘤的分子发病机制。
Leuk Lymphoma. 2017 Jul;58(7):1530-1537. doi: 10.1080/10428194.2016.1248965. Epub 2016 Nov 28.
9
Targeting p97 to Disrupt Protein Homeostasis in Cancer.靶向p97以破坏癌症中的蛋白质稳态。
Front Oncol. 2016 Aug 3;6:181. doi: 10.3389/fonc.2016.00181. eCollection 2016.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验